GlassScriptPhysician profile
Michael J Christofis
NPI 1710337878
$9,291.47
in general payments reported to CMS, 2019-2025
19 companies · $4,485 in 2025
The $4,485 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $110 · 2022: $116 · 2023: $2,623 · 2024: $1,850 · 2025: $4,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,300 · Food and Beverage: $2,023 · Travel and Lodging: $1,620 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,300.00 |
| Food and Beverage | $2,022.89 |
| Travel and Lodging | $1,620.32 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,310.05 | 2023-2025 | Da Vinci Surgical System, Davinci Xi |
| Aroa Biosurgery Incorporated | $124.95 | 2023 | |
| Baxter Healthcare | $113.88 | 2023 | Tisseel |
| Haemonetics Corporation | $110.16 | 2020 | |
| Becton, Dickinson and Company | $100.00 | 2019-2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $87.27 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Janssen Pharmaceuticals, INC | $87.16 | 2022 | |
| Bard Access Systems, INC. | $59.08 | 2019 | |
| Bard Peripheral Vascular, INC. | $58.10 | 2024 | Lutonix Drug Coated Balloon |
| Takeda Pharmaceuticals U.S.A., INC. | $46.47 | 2022-2023 | Gattex |
| Abbvie INC. | $28.55 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Kerecis Limited | $28.37 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Acera Surgical, INC. | $27.28 | 2025 | Restrata Wound Matrix |
| Organogenesis INC. | $24.08 | 2025 | Puraply Wound Matrix |
| Convatec INC. | $22.28 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.76 | 2024 | Andexxa |
| Kls-Martin L.P. | $16.72 | 2023 | |
| Zimmer Biomet Holdings, INC. | $16.22 | 2023 | Ribfix Blu Advantage |
| My01 INC. | $13.09 | 2023 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Christofis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.